company background image
XCRT logo

Xcelerate OTCPK:XCRT Stock Report

Last Price

US$0.023

Market Cap

US$9.9m

7D

43.6%

1Y

-57.6%

Updated

14 Jun, 2024

Data

Company Financials

XCRT Stock Overview

Acquires engineering/patents and applies to early-stage medical technology companies.

XCRT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Xcelerate Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xcelerate
Historical stock prices
Current Share PriceUS$0.023
52 Week HighUS$0.14
52 Week LowUS$0.014
Beta3.03
1 Month Change-32.77%
3 Month Change-52.29%
1 Year Change-57.59%
3 Year Change-81.64%
5 Year Change1,426.67%
Change since IPO-96.73%

Recent News & Updates

Recent updates

Shareholder Returns

XCRTUS HealthcareUS Market
7D43.6%-0.01%1.2%
1Y-57.6%6.1%20.6%

Return vs Industry: XCRT underperformed the US Healthcare industry which returned 5% over the past year.

Return vs Market: XCRT underperformed the US Market which returned 20.5% over the past year.

Price Volatility

Is XCRT's price volatile compared to industry and market?
XCRT volatility
XCRT Average Weekly Movement26.1%
Healthcare Industry Average Movement6.5%
Market Average Movement5.8%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

Stable Share Price: XCRT's share price has been volatile over the past 3 months.

Volatility Over Time: XCRT's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
199612Michael O’Sheawww.xcelerate.global

Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types.

Xcelerate Inc. Fundamentals Summary

How do Xcelerate's earnings and revenue compare to its market cap?
XCRT fundamental statistics
Market capUS$9.95m
Earnings (TTM)-US$2.75m
Revenue (TTM)US$1.12m

8.9x

P/S Ratio

-3.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XCRT income statement (TTM)
RevenueUS$1.12m
Cost of RevenueUS$827.97k
Gross ProfitUS$294.12k
Other ExpensesUS$3.04m
Earnings-US$2.75m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0063
Gross Margin26.21%
Net Profit Margin-245.14%
Debt/Equity Ratio-907.2%

How did XCRT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.